Navigation Links
BioMed Central welcomes the new National Institutes of Health public access policy

Yet another follow up of the NIH public access policy announced earlier this week, this time from free-access publisher BioMed Central :

BioMed Central welcomes the announcement of the US National Institutes of Health (NIH) new public access policy. The NIH calls on all of its grantees to deposit articles resulting from their NIH-funded research in the National Library of Medicine's PubMed Central and make them freely available within 12 months.

BioMed Central anticipates that many other funding bodies worldwide will now follow the example set by NIH.

All NIH grantees now have a new factor to take into account when choosing where they wish to publish their research. To fulfil the NIH request, authors publishing with most of the traditional subscription publishers will be expected to go through a process of resubmitting their papers to the PubMed Central repository. In addition, they will often need to update their manuscript version with the changes introduced in the publication process, as many publishers specify that only the author's version of the manuscript can be submitted to archives.

Those who choose to publish in any of BioMed Central's Open Access journals, which cover all areas of biology and medicine, are assured that the published version of their paper will be placed in PubMed Central for them, immediately and without any need for additional work from them. Researchers are thus saved the time and effort of going through the deposition process themselves.

This significant benefit is in addition to the rapid and high quality peer review, fast publication and high visibility of BioMed Central's Open Access journals.

BioMed Central urges all researchers in the life and medical sciences to fulfil the NIH request and to submit their future manuscripts to one of the 130 Open Access journals publishe d by BioMed Central.


'"/>

Source:BioMed Central


Related biology news :

1. BioMed Central launches Biology Direct
2. Impressive new Impact Factors for BioMed Centrals open-access journals
3. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
4. Parts of the Caribbean and Central America are likely to have less summer rain
5. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
6. National Academies advisory: Invasive aquatic species in the Great Lakes
7. Virginia Bioinformatics Institutes launches microbial database
8. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
9. Health costs soar as 60 million Americans classed as obese
10. Going To Extremes To Improve Human Health
11. Patient-choice C-section rate rises 36%: HealthGrades study
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today ... to uncover insights to support its reporting, help direct future ... UK,s leading youth charity will be using Brandwatch Analytics social listening ... better understanding of the topics and issues that are a priority ... ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... WuXi Biologics, a leading open-access R&D ... and a WuXi AppTec Affiliate, today announced that ... Excellence Award from IMAPAC, a leading consulting firm. ... recognize outstanding leaders and trend-setters of today, and ... biomanufacturing experts in the industry, along with the ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, ... oncology and drug-delivery therapies, today announced that an ... and Drug Administration voted 11 to 0 that ... skin) injection was favorable for patients in the ... lymphoma and chronic lymphocytic leukemia. The FDA action ...
(Date:3/29/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Agricultural Chelates ... over the next decade to reach approximately $825.4 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/29/2017)... , March 29, 2017 The Global Microfluidic ... report is a specialized and comprehensive study on the existing state ... America , Europe and ... Middle East and Africa . ... Browse 172 Tables and ...
Breaking Biology Technology: